Hümmert, M. W., Schöppe, L. M., Bellmann-Strobl, J., Siebert, N., Paul, F., Duchow, A., . . . Trebst, C. (2022). Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody–associated disease: CHANCENMO study. Neurology, 98(11), . https://doi.org/10.1212/WNL.0000000000200052
Chicago-Zitierstil (17. Ausg.)Hümmert, Martin W., et al. "Costs and Health-related Quality of Life in Patients with NMO Spectrum Disorders and MOG-antibody–associated Disease: CHANCENMO Study." Neurology 98, no. 11 (2022). https://doi.org/10.1212/WNL.0000000000200052.
MLA-Zitierstil (9. Ausg.)Hümmert, Martin W., et al. "Costs and Health-related Quality of Life in Patients with NMO Spectrum Disorders and MOG-antibody–associated Disease: CHANCENMO Study." Neurology, vol. 98, no. 11, 2022, https://doi.org/10.1212/WNL.0000000000200052.